<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02103309</url>
  </required_header>
  <id_info>
    <org_study_id>M-13-050</org_study_id>
    <nct_id>NCT02103309</nct_id>
  </id_info>
  <brief_title>Comparative Evaluation of Contact Lens Centering of DAILIES® AquaComfort Plus® Versus 1-DAY ACUVUE® MOIST® in Japan</brief_title>
  <official_title>Comparative Evaluation of Contact Lens Centering of DAILIES® AquaComfort Plus® Versus 1-DAY ACUVUE® MOIST®</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alcon Research</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alcon Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate lens centration and subjective impressions of
      DAILIES® AquaComfort Plus® (DACP) lenses compared to 1-DAY ACUVUE® MOIST® (1DAM) lenses in
      ball sports players.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Actual">November 2013</completion_date>
  <primary_completion_date type="Actual">November 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean Investigator-Rated Lens Centration</measure>
    <time_frame>After 1 week of wear</time_frame>
    <description>Lens centration was assessed by the investigator using slit-lamp microscopy and rated on a 5-point scale, where 0=Optimal and 4=Severe decentration. Both eyes contributed to the mean.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean Investigator-Rated Lens Fit</measure>
    <time_frame>After 1 week of wear</time_frame>
    <description>Lens fit was assessed by the investigator and rated on a 5-point scale with -2=Unacceptable tight fit, -1=Acceptable tight fit, 0=Optimal, 1=Acceptable loose fit, and 2=Uacceptable loose fit. Both eyes contributed to the mean.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average Subjective Ratings Score (Lens Handling and Overall Vision)</measure>
    <time_frame>After 1 week of wear</time_frame>
    <description>The participant rated the handling and overall vision of the contact lenses on a 10-point scale, where 10=Excellent and 1=Poor. Both eyes contributed to the mean.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average Subjective Ratings Score (Lens Wearing Conditions and Visual Performance During Ball Sports)</measure>
    <time_frame>After 1 week of wear</time_frame>
    <description>The participant rated the lens wearing conditions and visual performance of the contact lenses during ball sports on a 10-point scale, where 10=Agree and 1=Disagree. &quot;Overall Vision&quot; was rated with 10=Excellent and 1=Poor. Both eyes contributed to the mean.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">42</enrollment>
  <condition>Refractive Error</condition>
  <condition>Myopia</condition>
  <condition>Myopic Astigmatism</condition>
  <arm_group>
    <arm_group_label>DACP, then 1DAM</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Nelfilcon A contact lenses worn first, then etafilcon A contact lenses worn second. Each product worn bilaterally (in both eyes) for 1 week in a daily disposable mode.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>1DAM, then DACP</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Etafilcon A contact lenses worn first, then nelfilcon A contact lenses worn second. Each product worn bilaterally (in both eyes) for 1 week in a daily disposable mode.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nelfilcon A contact lenses</intervention_name>
    <arm_group_label>DACP, then 1DAM</arm_group_label>
    <arm_group_label>1DAM, then DACP</arm_group_label>
    <other_name>DAILIES® AquaComfort® Plus</other_name>
    <other_name>DACP</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Etafilcon A contact lenses</intervention_name>
    <arm_group_label>DACP, then 1DAM</arm_group_label>
    <arm_group_label>1DAM, then DACP</arm_group_label>
    <other_name>1-DAY ACUVUE® MOIST®</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Those who can understand the clinical study objectives and provide written informed
             consent. Legal representative or parental consent required if under age 20

          -  Those who regularly wear soft contact lenses in both eyes for a minimum of 8 hours per
             day and 5 days per week

          -  Those who play ball sports at least 1 day per week

          -  Those who need vision correction because of myopia or mild myopic astigmatism, who are
             eligible for use of the study device, and who can attain a visual acuity of at least
             1.0 with correction

          -  Other protocol-defined inclusion criteria may apply

        Exclusion Criteria:

          -  Those who regularly wear the study device

          -  Those who require ocular treatment with eye drops

          -  Those who have a condition contraindicating soft contact lens wear, such as eye
             irritation

          -  Those who have had ocular disorder or ocular surgery that may affect soft contact lens
             wear within 3 months before the start of the study

          -  Those who are participating in another clinical study or research or have a plan of
             such participation during the present study

          -  Women who are pregnant or intend to become pregnant during the study

          -  Other protocol-defined exclusion criteria may apply
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>29 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lisa L. Zoota, MPH, CCRA</last_name>
    <role>Study Director</role>
    <affiliation>Alcon Research</affiliation>
  </overall_official>
  <removed_countries>
    <country>Japan</country>
  </removed_countries>
  <verification_date>October 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 1, 2014</study_first_submitted>
  <study_first_submitted_qc>April 2, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 3, 2014</study_first_posted>
  <results_first_submitted>October 24, 2014</results_first_submitted>
  <results_first_submitted_qc>October 24, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">October 29, 2014</results_first_posted>
  <last_update_submitted>October 24, 2014</last_update_submitted>
  <last_update_submitted_qc>October 24, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 29, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Soft contact lenses</keyword>
  <keyword>DACP</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Astigmatism</mesh_term>
    <mesh_term>Refractive Errors</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants were recruited from 5 study centers located in Japan.</recruitment_details>
      <pre_assignment_details>This reporting group includes all enrolled participants.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>DACP, Then 1DAM</title>
          <description>Nelfilcon A contact lenses worn first, then etafilcon A contact lenses worn second. Each product worn bilaterally (in both eyes) for 1 week in a daily disposable mode.</description>
        </group>
        <group group_id="P2">
          <title>1DAM, Then DACP</title>
          <description>Etafilcon A contact lenses worn first, then nelfilcon A contact lenses worn second. Each product worn bilaterally (in both eyes) for 1 week in a daily disposable mode.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="22"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="22"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>This analysis population includes all enrolled participants.</population>
      <group_list>
        <group group_id="B1">
          <title>Overall</title>
          <description>DAILIES® AquaComfort Plus® and 1-Day ACUVUE® MOIST® contact lenses worn in a crossover assignment.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="42"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22.5" spread="2.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Mean Investigator-Rated Lens Centration</title>
        <description>Lens centration was assessed by the investigator using slit-lamp microscopy and rated on a 5-point scale, where 0=Optimal and 4=Severe decentration. Both eyes contributed to the mean.</description>
        <time_frame>After 1 week of wear</time_frame>
        <population>This analysis population includes all enrolled participants minus missing data.</population>
        <group_list>
          <group group_id="O1">
            <title>DACP</title>
            <description>Nelfilcon A contact lenses worn bilaterally (in both eyes) for 1 week in a daily disposable mode.</description>
          </group>
          <group group_id="O2">
            <title>1DAM</title>
            <description>Etafilcon A contact lenses worn bilaterally (in both eyes) for 1 week in a daily disposable mode.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Investigator-Rated Lens Centration</title>
          <description>Lens centration was assessed by the investigator using slit-lamp microscopy and rated on a 5-point scale, where 0=Optimal and 4=Severe decentration. Both eyes contributed to the mean.</description>
          <population>This analysis population includes all enrolled participants minus missing data.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="41"/>
                <count group_id="O2" value="39"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.34" spread="0.47"/>
                    <measurement group_id="O2" value="0.73" spread="0.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Investigator-Rated Lens Fit</title>
        <description>Lens fit was assessed by the investigator and rated on a 5-point scale with -2=Unacceptable tight fit, -1=Acceptable tight fit, 0=Optimal, 1=Acceptable loose fit, and 2=Uacceptable loose fit. Both eyes contributed to the mean.</description>
        <time_frame>After 1 week of wear</time_frame>
        <population>This analysis population includes all enrolled participants minus missing data.</population>
        <group_list>
          <group group_id="O1">
            <title>DACP</title>
            <description>Nelfilcon A contact lenses worn bilaterally (in both eyes) for 1 week in a daily disposable mode.</description>
          </group>
          <group group_id="O2">
            <title>1DAM</title>
            <description>Etafilcon A contact lenses worn bilaterally (in both eyes) for 1 week in a daily disposable mode.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Investigator-Rated Lens Fit</title>
          <description>Lens fit was assessed by the investigator and rated on a 5-point scale with -2=Unacceptable tight fit, -1=Acceptable tight fit, 0=Optimal, 1=Acceptable loose fit, and 2=Uacceptable loose fit. Both eyes contributed to the mean.</description>
          <population>This analysis population includes all enrolled participants minus missing data.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="41"/>
                <count group_id="O2" value="39"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.24" spread="0.42"/>
                    <measurement group_id="O2" value="0.28" spread="0.50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Average Subjective Ratings Score (Lens Handling and Overall Vision)</title>
        <description>The participant rated the handling and overall vision of the contact lenses on a 10-point scale, where 10=Excellent and 1=Poor. Both eyes contributed to the mean.</description>
        <time_frame>After 1 week of wear</time_frame>
        <population>This analysis population includes all enrolled participants minus missing data.</population>
        <group_list>
          <group group_id="O1">
            <title>DACP</title>
            <description>Nelfilcon A contact lenses worn bilaterally (in both eyes) for 1 week in a daily disposable mode.</description>
          </group>
          <group group_id="O2">
            <title>1DAM</title>
            <description>Etafilcon A contact lenses worn bilaterally (in both eyes) for 1 week in a daily disposable mode.</description>
          </group>
        </group_list>
        <measure>
          <title>Average Subjective Ratings Score (Lens Handling and Overall Vision)</title>
          <description>The participant rated the handling and overall vision of the contact lenses on a 10-point scale, where 10=Excellent and 1=Poor. Both eyes contributed to the mean.</description>
          <population>This analysis population includes all enrolled participants minus missing data.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="42"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Ease of insertion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.8" spread="2.0"/>
                    <measurement group_id="O2" value="6.4" spread="2.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ease of removal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.2" spread="2.5"/>
                    <measurement group_id="O2" value="8.2" spread="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Overall vision</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.1" spread="1.9"/>
                    <measurement group_id="O2" value="7.4" spread="2.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Average Subjective Ratings Score (Lens Wearing Conditions and Visual Performance During Ball Sports)</title>
        <description>The participant rated the lens wearing conditions and visual performance of the contact lenses during ball sports on a 10-point scale, where 10=Agree and 1=Disagree. “Overall Vision” was rated with 10=Excellent and 1=Poor. Both eyes contributed to the mean.</description>
        <time_frame>After 1 week of wear</time_frame>
        <population>This analysis population includes all enrolled participants minus missing data.</population>
        <group_list>
          <group group_id="O1">
            <title>DACP</title>
            <description>Nelfilcon A contact lenses worn bilaterally (in both eyes) for 1 week in a daily disposable mode.</description>
          </group>
          <group group_id="O2">
            <title>1DAM</title>
            <description>Etafilcon A contact lenses worn bilaterally (in both eyes) for 1 week in a daily disposable mode.</description>
          </group>
        </group_list>
        <measure>
          <title>Average Subjective Ratings Score (Lens Wearing Conditions and Visual Performance During Ball Sports)</title>
          <description>The participant rated the lens wearing conditions and visual performance of the contact lenses during ball sports on a 10-point scale, where 10=Agree and 1=Disagree. “Overall Vision” was rated with 10=Excellent and 1=Poor. Both eyes contributed to the mean.</description>
          <population>This analysis population includes all enrolled participants minus missing data.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="42"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Sense of discomfort</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.5" spread="2.6"/>
                    <measurement group_id="O2" value="3.8" spread="2.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A lens comes off my eye</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.4" spread="2.2"/>
                    <measurement group_id="O2" value="2.5" spread="2.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A lens becomes out of place</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.3" spread="2.5"/>
                    <measurement group_id="O2" value="4.0" spread="2.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Improves my vision/widens my vision</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.3" spread="2.4"/>
                    <measurement group_id="O2" value="5.8" spread="2.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>My vision does not become blurry</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.3" spread="2.5"/>
                    <measurement group_id="O2" value="6.0" spread="2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Do not lose a sense of perspective/distance</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.8" spread="3.3"/>
                    <measurement group_id="O2" value="6.4" spread="2.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Does not give me improper vision</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.4" spread="2.2"/>
                    <measurement group_id="O2" value="7.1" spread="2.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Enables me to see clearly at important occasion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.9" spread="2.4"/>
                    <measurement group_id="O2" value="6.5" spread="2.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Improves my vision when playing sports</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.6" spread="2.5"/>
                    <measurement group_id="O2" value="6.3" spread="2.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Overall vision</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.2" spread="2.1"/>
                    <measurement group_id="O2" value="7.1" spread="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events (AEs) were collected for the duration of the study (1 month). This analysis group includes (Safety Population). based on treatment-specific exposure</time_frame>
      <desc>An AE was defined as any untoward medical occurrence, unintended disease or injury, or untoward clinical signs (including abnormal laboratory findings) in patients, users or other persons, whether or not related to the medical device.</desc>
      <group_list>
        <group group_id="E1">
          <title>DACP</title>
          <description>Nelfilcon A contact lenses worn bilaterally (in both eyes) for 1 week in a daily disposable mode.</description>
        </group>
        <group group_id="E2">
          <title>1DAM</title>
          <description>Etafilcon A contact lenses worn bilaterally (in both eyes) for 1 week in a daily disposable mode.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="42"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="42"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Sponsor reserves the right of prior review of any publication or presentation of information related to the study.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Director of Clinical Trials</name_or_title>
      <organization>Alcon Japan, Ltd.</organization>
      <phone>1-888-451-3937</phone>
      <email>alcon.medinfo@alcon.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

